跳至主要内容
临床试验/IRCT20211203053263N3
IRCT20211203053263N3招募中3 期

The Effect of capsules containing sucralfate/sodium alginate in patients with refractory gastroesophageal reflux disease

Ilam University of Medical Sciences0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Patients who remained symptomatic (assessed by daily reflux questionnaire) with a standard dose of PPI after a trial period of treatment of at least 2 months.

排除标准

  • non-compliant
  • inappropriate use of PPI
  • Other diseases that can mimic the symptoms of GERD include achalasia, eosinophilic esophagitis, infectious esophagitis, pill esophagitis, gastroparesis, and esophageal stricture or cancer and functional dyspepsia according to the Rome4 criteria.

研究者

发起方
Ilam University of Medical Sciences

相似试验